Navigation Links
Epigenetic signatures direct the repair potential of reprogrammed cells
Date:3/14/2012

BOSTON (March 14, 2012) A research team has identified epigenetic signatures, markers on DNA that control transient changes in gene expression, within reprogrammed skin cells. These signatures can predict the expression of a wound-healing protein in reprogrammed skin cells or induced pluripotent stem cells (iPSCs), cells that take on embryonic stem cell properties. Understanding how the expression of the protein is controlled brings us one step closer to developing personalized tissue regeneration strategies using stem cells from a patient, instead of using human embryonic stem cells. The study was published in the Journal of Cell Science.

When skin cells are reprogrammed, many of their cellular properties are recalibrated as they aquire stem cell properties and then are induced to become skin cells again. In order for these "induced" stem cells to be viable in treatment for humans (tissue regeneration, personalized wound healing therapies, etc.), researchers need to understand how they retain or even improve their characteristics after they are reprogrammed.

Since the initial discovery of reprogramming, scientists have struggled with the unpredictability of the cells due to the many changes that occur during the reprogramming process. Classifying specific epigenetic signatures, as this study did, allows researchers to anticipate ways to produce cell types with optimal properties for tissue repair while minimizing unintended cellular abnormalities.

The researchers used reprogrammed cells to generate three-dimensional connective tissue that mimics an in vivo wound repair environment. To verify the role of the protein (PDGFRbeta) in tissue regeneration and maintenance, the team blocked its cellular expression, which impaired the cells' ability to build tissue.

"We determined that successful tissue generation is associated with the expression of PDGFRbeta. Theoretically, by identifying the epigenetic signatures that indicate its expression, we can determine the reprogrammed cells' potential for maintaining normal cellular characteristics throughout development," said first author Kyle Hewitt, PhD, a graduate of the cell, molecular & developmental biology program at the Sackler School of Graduate Biomedical Sciences, and postdoctoral associate in the Garlick laboratory at Tufts University School of Dental Medicine (TUSDM).

"The ability to generate patient-specific cells from the reprogrammed skin cells may allow for improved, individualized, cell-based therapies for wound healing. Potentially, these reprogrammed cells could be used as a tool for drug development, modeling of disease, and transplantation medicine without the ethical issues associated with embryonic stem cells," said senior author Jonathan Garlick, DDS, PhD, a professor in the department of oral and maxillofacial pathology and director of the division of tissue engineering and cancer biology at TUSDM.

Jonathan Garlick is also a member of the cell, molecular & developmental biology program faculty at the Sackler School and the director of the Center for Integrated Tissue Engineering (CITE) at TUSDM.


'/>"/>

Contact: Jessica McGovern
jessica.mcgovern@tufts.edu
617-636-6586
Tufts University, Health Sciences Campus
Source:Eurekalert

Related biology news :

1. CSHL scientists discover a new way in which epigenetic information is inherited
2. CSHL researchers map changing epigenetic modifications that enable transposons to run amok
3. Growth of new brain cells requires epigenetic switch
4. Ali Shilatifard and colleagues aim to clarify the definition of epigenetics
5. New nucleotide could revolutionize epigenetics
6. New piece found in the puzzle of epigenetics
7. Scientists take early steps toward mapping epigenetic variability
8. Epigenetics could help researchers determine any risks associated with low-dose radiation
9. Genomes of identical twins reveal epigenetic changes that may play role in lupus
10. UBC geneticist reveals molecular view of key epigenetic regulator
11. Epigenetic concepts offer new approach to degenerative disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... , Feb. 28, 2017   Acuant , a ... globally, announces significant enhancements to new and core technologies ... New products include mobile and desktop Acuant FRM TM ... - a real time manual review of identity ... technology provides the fastest and most accurate capture software ...
(Date:2/26/2017)... , Feb. 25, 2017  Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring, ... and Reentry. "Too often, too many ... and county jails are trying to tackle this ... and friends and family members. While significant steps are ...
(Date:2/21/2017)... , February 21, 2017 Der ... US-Dollar wachsen. Nach einem Gespräch mit mehr als 50 Vertretern ... Hindernisse zu überwinden gilt, um diese Prognose zu realisieren. ... ... die Mobilisierung der finanziellen Mittel für die Biobank, die ...
Breaking Biology News(10 mins):
(Date:3/30/2017)... , March 30, 2017 In ... Inc. (NASDAQ: AGEN), Intrexon Corp. (NYSE: XON), Progenics Pharmaceuticals ... CXRX ). According an article on Barron,s, Credit ... Weight" on Tuesday, March 21 st , 2017. These stocks ... for free at: ...
(Date:3/29/2017)... Inc. (NASDAQ: VRML), a bio-analytical solutions company focused ... the fourth quarter and full year ended December ... year for us with our first clinical utility ... reimbursement progress with Medicare, positive medical policy coverage ... cleared our 2 nd generation product Overa ...
(Date:3/29/2017)... PETACH TIKVAH, Israel , ... Inc. (NASDAQ: BCLI), a leading developer of ... announced financial results for the year ended ... a highly successful and pivotal year for Brainstorm, with ... progress made on clinical, regulatory and operational fronts," ...
(Date:3/29/2017)... ... 29, 2017 , ... On the heels of the globally recognized Rare ... has announced that it will manage travel services for its 500th clinical trial this ... United States and Europe to offer travel management services specifically for clinical trials and ...
Breaking Biology Technology: